BDDCS Applied to Over 900 Drugs

作者: Leslie Z. Benet , Fabio Broccatelli , Tudor I. Oprea

DOI: 10.1208/S12248-011-9290-9

关键词: SolubilityActive metaboliteBiopharmaceuticsIn silicoPharmacologyPolar surface areaChemistryTransporterEffluxPharmacokinetics

摘要: Here, we compile the Biopharmaceutics Drug Disposition Classification System (BDDCS) classification for 927 drugs, which include 30 active metabolites. Of 897 parent 78.8% (707) are administered orally. Where lowest measured solubility is found, this value reported 72.7% (513) of these orally drugs and a dose number recorded. The values percent excreted unchanged in urine, LogP, LogD 7.4 when available. For all compounds, silico parameters predicted Log water, calculated polar surface area, hydrogen bond acceptors donors moiety also provided, thereby allowing comparison analyses both experimentally values. We discuss potential use BDDCS to estimate disposition characteristics novel chemicals (new molecular entities) early stages drug discovery development. Transporter effects intestine liver not clinically relevant class 1 but potentially can have high impact 2 (efflux gut, efflux uptake liver) 3 (uptake gut drugs. A combination low likely cause 4 be underpopulated terms approved (N = 53 compared with over 200 each classes 1–3). influence several process category assignment discussed detail.

参考文章(49)
Tudor I. Oprea, Current trends in lead discovery: Are we looking for the appropriate properties? Journal of Computer-aided Molecular Design. ,vol. 16, pp. 325- 334 ,(2002) , 10.1023/A:1020877402759
Tarun M Kapoor, Günther Wess, Stuart L. Schreiber, Chemical biology : from small molecules to systems biology and drug design Wiley-VCH. ,(2007)
Gordon L. Amidon, Hans Lennernäs, Vinod P. Shah, John R. Crison, A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability Pharmaceutical Research. ,vol. 12, pp. 413- 420 ,(1995) , 10.1023/A:1016212804288
Marius Olah, Ramona Rad, Liliana Ostopovici, Alina Bora, Nicoleta Hadaruga, Dan Hadaruga, Ramona Moldovan, Adriana Fulias, Maria Mractc, Tudor I. Oprea, WOMBAT and WOMBAT‐PK: Bioactivity Databases for Lead and Drug Discovery John Wiley & Sons, Ltd. pp. 760- 786 ,(2008) , 10.1002/9783527619375.CH13B
Danna L Ross, Christopher M Riley, None, Aqueous solubilities of some variously substituted quinolone antimicrobials International Journal of Pharmaceutics. ,vol. 63, pp. 237- 250 ,(1990) , 10.1016/0378-5173(90)90130-V
Leslie Z. Benet, The drug transporter-metabolism alliance: uncovering and defining the interplay. Molecular Pharmaceutics. ,vol. 6, pp. 1631- 1643 ,(2009) , 10.1021/MP900253N
M Wadelius, K Sörlin, O Wallerman, J Karlsson, Q-Y Yue, P K E Magnusson, C Wadelius, H Melhus, Warfarin sensitivity related to CYP2C9, CYP3A5, ABCB1 (MDR1) and other factors Pharmacogenomics Journal. ,vol. 4, pp. 40- 48 ,(2004) , 10.1038/SJ.TPJ.6500220
A Frymoyer, S Shugarts, M Browne, A H B Wu, L Frassetto, L Z Benet, Effect of Single‐Dose Rifampin on the Pharmacokinetics of Warfarin in Healthy Volunteers Clinical Pharmacology & Therapeutics. ,vol. 88, pp. 540- 547 ,(2010) , 10.1038/CLPT.2010.142
Stefan Willmann, Walter Schmitt, Jörg Keldenich, Jörg Lippert, Jennifer B. Dressman, A physiological model for the estimation of the fraction dose absorbed in humans. Journal of Medicinal Chemistry. ,vol. 47, pp. 4022- 4031 ,(2004) , 10.1021/JM030999B
William M. Meylan, Philip H. Howard, Robert S. Boethling, Improved method for estimating water solubility from octanol/water partition coefficient Environmental Toxicology and Chemistry. ,vol. 15, pp. 100- 106 ,(1996) , 10.1002/ETC.5620150205